Trends in Cardiovascular Mortality Associated With Systemic Connective Tissue Disorders in the United States: A 22‐Year Population‐Based National Analysis (1999–2020)
AIM: To examine national trends and disparities in cardiovascular mortality associated with systemic connective tissue disorders (CTDs) in the United States from 1999 to 2020. METHODS: We analyzed mortality data from the CDC WONDER database. Deaths were included where CTD (ICD-10: M05, M06, M30-M35) was the underlying cause and cardiovascular disease was a contributing cause. Age-adjusted mortality rates (AAMRs) per 1 000 000 were calculated using the 2000 US Standard Population. Joinpoint regression identified annual and average annual percentage changes. Analyses were stratified by sex, race/ethnicity, census region, and urbanization. Disease subgroup and state-level analyses were performed. RESULTS: Between 1999 and 2020, 47 752 cardiovascular deaths occurred among individuals with systemic CTDs. The national AAMR declined from 14.4 to 8.2 per 1 000 000 (AAPC: -2.68%, 95% CI: -2.89 to -2.47, p < 0.001). Females had consistently higher mortality than males (average AAMR: 13.5 vs. 5.9 per 1 000 000; p < 0.001). Non-Hispanic Black individuals had the highest rates (average AAMR: 14.9 per 1 000 000), with widening disparities after 2008. Rural areas had higher mortality than urban areas (average AAMR: 11.4 vs. 9.9 per 1 000 000; p = 0.01). Subgroup analyses revealed heterogeneous trends across CTD subtypes, with SLE showing the slowest improvement (AAPC: -1.87%) and dermatomyositis the steepest decline (AAPC: -4.98%). State-level AAMRs ranged 2.2-fold, from 6.3 (District of Columbia) to 13.6 (Montana) per 1 000 000. CONCLUSIONS: Cardiovascular mortality associated with systemic CTDs has declined significantly over two decades; however, persistent racial disparities, urban-rural differences, heterogeneous disease-specific trends, and substantial geographic variation underscore the need for targeted, equitable interventions in this high-risk population.
Authors
- Martin E. Matsumura (ORCID: https://orcid.org/0000-0001-9303-0978)
- Samuel Mensah (ORCID: https://orcid.org/0000-0002-0835-5450)
- Isaac Opoku
- Gregory Atafo
- Ikponmwosa Jude Ogieuhi (ORCID: https://orcid.org/0009-0003-9465-0089)
- Albert Orhin
- Chukwuemeka Aghasili
- Nathaniel Eyiah
- Reuben Laryea Odai
- Manfred Mate‐Kole (ORCID: https://orcid.org/0009-0006-8768-7993)
- Timothy Kopah (ORCID: https://orcid.org/0009-0003-2148-1923)
Institutions
- West Virginia University (US)
- Beth Israel Deaconess Medical Center (US)
- Johns Hopkins University (US)
- University of Kansas (US)
- Bridgeport Hospital (US)
- Centegra Hospital McHenry (US)
- Ho Technical University (GH)
- PRN of Kansas (US)
- Geisinger Wyoming Valley Medical Center (US)
- 37 Military Hospital (GH)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1111/1756-185x.70681
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00